COMMUNIQUÉS West-GlobeNewswire

PDS Biotechnology Prioritizes Development of PDS0101 in Advanced Cancers Following Promising Phase 1 Clinical Outcome Data
01/10/2019
Data demonstrated regression of lesions in 60% of patients BERKELEY HEIGHTS, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology [...]
Agritek Holdings, Inc. Announces Agreement with Leading California Manufacturing Facility Apex Solutions Ending Third Quarter with $200,000 in New Purchase Orders
01/10/2019
LOS ANGELES, CA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant [...]
REPEAT - Integrated Cannabis’ Ganja Gold takes Delivery of Fully Automated Proprietary Pre-Roll Manufacturing Machine
01/10/2019
VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), a multi-state brand operator in California and [...]
Align Technology to Announce Third Quarter 2019 Results on October 23, 2019
01/10/2019
SAN JOSE, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2019 financial results on Wednesday, October 23, 2019, after the close [...]
TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer
01/10/2019
Study results demonstrate that oral SM-88 may play a clinically meaningful role in postponing use of hormonal castration in prostate cancer patients with rising prostate-specific antigen (PSA): More than 450,000 of [...]
BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®
01/10/2019
Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million Lives Symproic Will be Listed as Preferred Exclusive and BELBUCA Preferred or Preferred Exclusive RALEIGH, N.C., Oct. 01 [...]
Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus and Related Viruses
01/10/2019
BOTHELL, WA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today [...]
Lantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments
01/10/2019
Collaboration will leverage Lantern’s proprietary AI platform and NCI’s platform to better predict patients’ tumor responses to specific drug classes and therapeutics DALLAS and KEARNY, N.J., Oct. 01, 2019 (GLOBE [...]
BeyondSpring Presents Novel Trial Design for DUBLIN-3 Study BPI-2358-103 at ESMO Congress 2019
01/10/2019
DUBLIN-3 Designed to Overcome Challenges Associated with Trial Failure Risk, According to New Data in Non-Small Cell Lung Cancer Studies NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a [...]
Xeris Pharmaceuticals Appoints Mark Thierer to Board of Directors
01/10/2019
CHICAGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use [...]
Conformis and Stryker Execute Development, License and Distribution Agreements
01/10/2019
Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit [...]
BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures
01/10/2019
SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the U.S. commercial [...]
Ziopharm Oncology Announces FDA Clearance of IND for Rapid Personalized Manufacture of CD19-specific CAR-T
01/10/2019
– Phase 1 clinical trial of CAR-T produced and infused in two days or less from gene transfer using Ziopharm’s Sleeping Beauty platform – – Rapid personalized manufacture of CD19-specific CAR-T for investigation in [...]
Replimune to Present at Chardan’s 3rd Annual Genetic Medicines Conference
01/10/2019
WOBURN, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that Robert [...]
Vaxart to Present Clinical Data From its Norovirus Phase 1b Study at Three Global Healthcare Conferences in October 2019
01/10/2019
ID Week (Washington, DC), 7th International Calicivirus Conference (Sydney, AU) and the 10th International Vaccines for Enteric Diseases (Lausanne, CH) SOUTH SAN FRANCISCO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- [...]
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
01/10/2019
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, announces the appointment of Michael Garone as [...]
Biogen Announces Leadership Update
01/10/2019
Dr. Alfred Sandrock is named Executive Vice President, Research and Development and continues as Chief Medical Officer Dr. Alphonse Galdes appointed Executive Vice President, Pharmaceutical Operations and Technology Dr [...]
Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products
01/10/2019
MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD Therapeutics Inc [...]
Editas Medicine to Participate in Upcoming Investor Conferences
01/10/2019
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences [...]

Pages